SPECIES DIVERSITY AND SENSITIVITY TO ANTIBIOTICS AGAINST ORAL STREPTOCOCCI ISOLATED IN CHILDREN
Oral streptococci can exchange genetic material with other bacteria colonizing the same loci of the body, their resistance profiles can serve as markers of the risk of the developing resistance to certain antibiotics in closely related bacteria, in particular, Streptococcus pneumoniae. Materials and Methods To describe the species composition of oral streptococci and to detect the profile of their sensitivity to a wide range of antibiotics there were investigated oral streptococcal isolates isolated from oropharyngeal smears sown in children of various ages with acute respiratory infections not receiving antibacterial therapy for selective streptococcal medium with penicillin (Pen, 1 mg/l) or erythromycin (Ery, 2 mg/l). 253 oropharyngeal smears were studied. Results. The most frequent sowings were Pen-resistant and Ery-resistant Streptococcus mitis, found in 158 (62.5%) and 169 (66.8%) studied, respectively. Ery-resistant Streptococcus salivarius group was detected in 107 (42.3%) samples, Pen-resistant streptococcus from this group were found much less frequently in 16 (6.3%) samples. Pen and Eri-resistant isolates of Streptococcus sanguinis group were present in 69 (27.3%) and 49 (19.4%) samples respectively. All the streptococcus specimens studied were sensitive to vancomycin, linezolid and (except for one) levofloxacin; about 90% were sensitive to daptomycin, rifampicin and chloramphenicol. Sensitivity to tetracycline was lower at 57.5%. Multiple drug resistance (MDR; resistance to ≥3 groups of antibiotics) had 93 (58.1%) isolates; the most common combination of penicillin, erythromycin and tetracycline resistance was found in 53 (57%) MDR isolates. Streptococcus mitis/oralis were characterized by higher MPCs of penicillin, ampicillin and ceftriaxone, as well as the frequency of stable forms, including MDR, as compared to other streptococci. Streptococcus mitis, first S. mitis oralis group streptococcus predominate in the species structure of antibiotic-resistant oral streptocococci, among which MDR is widespread, including resistance to β-lactams.
About the authorsMayanskiy N.A.
Kulichenko Tatyana V.
Baranov A.A., Briko N.I., Namazova-Baranova L.S., Ryapis L.A. Streptococcus and Pneumococcus. [Streptokokki I pnevmokokki]. Rostov-on-Don: Phoenix, 2013.
Doern CD, Burnham CA. It’s not easy being green: the viridans group streptococci, with a focus on pediatric clinical manifestations. J Clin Microbiol. 2010; 48(11): 3829-35. doi: 10.1128/JCM.01563-10.
Brenciani A, Tiberi E, Tili E, Mingoia M, Palmieri C, Varaldo PE, et al. Genetic determinants and elements associated with antibiotic resistance in viridans group streptococci. J Antimicrob Chemother. 2014; 69(5): 1197-204. doi: 10.1093/jac/dkt495.
Facklam R. What happened to the streptococci: overview of taxonomic and nomenclature changes. Clin Microbiol Rev. 2002; 15(4): 613-30.
Spellerberg B, Brandt C. Streptococcus. In: Versalovic J, Carroll KC, Funke G, Jorgensen JH, Landry ML and Warnock DW (ed.), Manual of Clinical Microbiology, 10th edition, ASM Press, Washington, DC, 2011; 331-49.
Póntigo F, Moraga M, Flores SV. Molecular phylogeny and a taxonomic proposal for the genus Streptococcus. Genet Mol Res. 2015; 14(3): 10905-18. doi: 10.4238/2015.
Mayansky N.A., Kalakutskaya A.N., Motuzova O.V., Lominadze G.G., Kryzhanovskaya O.A., Katosova L.K. MALDI-TOF mass spectrometry in routine work of microbiological laboratory. Diagnostics issues in pediatrics. 2011; 3(5): 20-5.
Angeletti S, Dicuonzo G, Avola A, Crea F, Dedej E, Vailati F et al. Viridans Group Streptococci clinical isolates: MALDI-TOF mass spectrometry versus gene sequence-based identification. PLoS One. 2015; 10(3): e0120502. doi: 10.1371/journal.pone.0120502.
Harju I, Lange C, Kostrzewa M, Maier T, Rantakokko-Jalava K, Haanperä M. Improved Differentiation of Streptococcus pneumoniae and Other S. mitis Group Streptococci by MALDI Biotyper Using an Improved MALDI Biotyper Database Content and a Novel Result Interpretation Algorithm. J Clin Microbiol. 2017; 55(3): 914-22. doi: 10.1128/JCM.01990-16.
Su TY, Lee MH, Huang CT, Liu TP, Lu JJ. The clinical impact of patients with bloodstream infection with different groups of Viridans group streptococci by using matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS). Medicine (Baltimore). 2018; 97(50): e13607. doi: 10.1097/MD.0000000000013607.
Ioannidou S, Papaparaskevas J, Tassios PT, Foustoukou M, Legakis NJ, Vatopoulos AC. Prevalence and characterization of the mechanisms of macrolide, lincosamide and streptogramin resistance in viridans group streptococci. Int J Antimicrob Agents. 2003; 22(6): 626-9.
Ergin A, Ercis S, Hasçelik G. Macrolide resistance mechanisms and in vitro susceptibility patterns of viridans group streptococci isolated from blood cultures. J Antimicrob Chemother. 2006; 57(1): 139-41.
Chun S, Huh HJ, Lee NY. Species-specific difference in antimicrobial susceptibility among viridans group streptococci. Ann Lab Med. 2015; 35(2): 205-11. doi: 10.3343/alm.2015.35.2.205.
Mayansky N.A., Kvarchiya A.Z., Ponomarenko O.A., Lazareva A.V., Kulichenko T.V. Carrying oral streptococcus resistant to penicillin and erythromycin in children with acute respiratory infections. Rossiyskiy pediatricheskiy zhurnal. 2018; 21(6): 337-44. DOI: http://dx.doi.org/10.18821/1560-9561-2018-21-6-337-344.
Mayanskiy N, Alyabieva N, Ponomarenko O, Pakhomov A, Kulichenko T, Ivanenko A. et al. Bacterial etiology of acute otitis media and characterization of pneumococcal serotypes and genotypes among children in Moscow, Russia. Pediatr Infect Dis J. 2015; 34(3): 255-60. doi: 10.1097/INF.0000000000000554.
CLSI M100 ED29:2019 - Performance Standards for Antimicrobial Susceptibility Testing, 29th Edition.
Mayansky N.A., Alyabieva N.M., Ponomarenko O.A., Kulichenko T.V., Artemova I.V., Lazareva A.V. et al. Dynamics of serotypes prevalence and antibiotic resistance of nasopharyngeal pneumococcal patients in children in 2010-2016: results of a retrospective cohort study. Issues of modern pediatrics. 2017; 16 (5): 413-23. doi: 10.15690/vsp.v16i5.1806).
Rodriguez-Avial I, Rodriguez-Avial C, Culebras E, Picazo JJ. Distribution of tetracycline resistance genes tet(M), tet(O), tet(L) and tet(K) in blood isolates of viridans group streptococci harbouring erm(B) and mef(A) genes. Susceptibility to quinupristin/dalfopristin and linezolid. Int J Antimicrob Agents. 2003; 21(6): 536-41.
Smith A, Jackson MS, Kennedy H. Antimicrobial susceptibility of viridans group streptococcal blood isolates to eight antimicrobial agents. Scand J Infect Dis. 2004; 36(4): 259-63.
Rozkiewicz D, Daniluk T, Sciepuk M, Zaremba ML, Cylwik-Rokicka D, Luczaj-Cepowicz E. et al. Prevalence rate and antibiotic susceptibility of oral viridans group streptococci (VGS) in healthy children population. Adv Med Sci. 2006; 51 Suppl 1: 191-5.
Nielsen MJ, Claxton S, Pizer B, Lane S, Cooke RP, Paulus S et al. Viridans Group Streptococcal Infections in Children After Chemotherapy or Stem Cell Transplantation: A 10-year Review From a Tertiary Pediatric Hospital. Medicine (Baltimore). 2016; 95(9): e2952. doi: 10.1097/MD.0000000000002952.
Süzük S, Kaşkatepe B, Çetin M. Antimicrobial susceptibility against penicillin, ampicillin and vancomycin of viridans group Streptococcus in oral microbiota of patients at risk of infective endocarditis. Infez Med. 2016; 24(3): 190-3.
Hakenbeck R, Brückner R, Denapaite D, Maurer P. Molecular mechanisms of β-lactam resistance in Streptococcus pneumoniae. Future Microbiol. 2012; 7: 395-410.
Chi F, Nolte O, Bergmann C, Ip M, Hakenbeck R. Crossing the barrier: evolution and spread of a major class of mosaic pbp2x in S. pneumoniae, S. mitis and S oralis. Int J Med Microbiol.2007; 297: 503-12. doi.org/10.1016/j.ijmm.
Jensen A, Valdorsson O, Frimodt-Moller N, Hollingshead S, Kilian M. Commensal streptococci serve as a reservoir for beta-lactam resistance genes in Streptococcus pneumoniae. Antimicrob Agents Chemother. 2015; 59: 3529-40. doi.org/10.1128/AAC.00429-15.
Leclercq R. Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications. Clin Infect Dis. 2002; 34: 482-492.
Schroeder MR, Stephens DS. Macrolide Resistance in Streptococcus pneumoniae. Front Cell Infect Microbiol. 2016; 6: 98.
van der Linden M, Otten J, Bergmann C, Latorre C, Liñares J, Hakenbeck R. Insight into the Diversity of Penicillin-Binding Protein 2x Alleles and Mutations in Viridans Streptococci. Antimicrob Agents Chemother. 2017; 61(5). doi: 10.1128/AAC.02646-16.
Katosova L.K., Lazareva A.V., Khokhlova T.A., Ponomarenko O.A., Alyabieva N.M. Distribution and mechanisms of resistance to Streptococcus pyogenes macrolides isolated in children. Antibiotiki i khimiotherapiya. 2016; 61(3-4): 23-9.
Shaikh N, Leonard E, Martin JM. Prevalence of streptococcal pharyngitis and streptococcal carriage in children: a meta-analysis. Pediatrics. 2010; 126(3): e557-64. doi: 10.1542/peds.2009-2648.
- Refbacks are not listed
Контент доступен под лицензией Creative Commons Attribution 3.0 License.